Compare Stocks → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:ABCNYSEAMERICAN:BTGTSE:PLI Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCABcann GlobalC$0.00C$0.00▼C$0.00N/AN/AN/AN/ABTGB2Gold$2.60+0.8%$2.88$2.34▼$4.29$3.39B1.0912.04 million shs1.01 million shsPLIProMetic Life SciencesC$13.60C$7.13▼C$590.00C$317.06MN/A8,002 shs921 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTGB2Gold0.00%-10.03%+4.42%-5.80%-38.82%PLIProMetic Life Sciences0.00%0.00%0.00%0.00%0.00%What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABCABcann GlobalN/AN/AN/AN/AN/AN/AN/AN/ABTGB2Gold4.573 of 5 stars3.35.01.70.03.91.73.1PLIProMetic Life SciencesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABCABcann GlobalN/AN/AN/AN/ABTGB2Gold2.50Moderate Buy$4.8586.54% UpsidePLIProMetic Life SciencesN/AN/AN/AN/ACurrent Analyst RatingsLatest ABC, BTG, CUV, and PLI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/28/2024BTGB2GoldRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform$4.00 ➝ $3.502/29/2024BTGB2GoldJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.50(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABCABcann GlobalN/AN/AN/AN/AN/AN/ABTGB2Gold$1.93B1.75$0.59 per share4.40$3.00 per share0.87PLIProMetic Life SciencesC$39.91M0.00N/A3.94C$6.07 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABCABcann GlobalN/AN/A0.00N/AN/AN/AN/AN/AN/ABTGB2Gold$10.10M$0.02130.076.191.530.31%9.09%7.54%5/7/2024 (Estimated)PLIProMetic Life SciencesN/A-C$63.06N/AN/AN/AN/AN/AN/AN/ALatest ABC, BTG, CUV, and PLI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/22/2024Q4 2023BTGB2Gold$0.08$0.07-$0.01$0.23$512.00 million$511.97 million DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABCABcann GlobalN/AN/AN/AN/AN/ABTGB2Gold$0.083.08%+13.30%400.20%N/APLIProMetic Life SciencesN/AN/AN/AN/AN/ALatest ABC, BTG, CUV, and PLI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/21/2024BTGB2Goldquarterly$0.046.4%3/6/20243/7/20243/20/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABCABcann GlobalN/AN/AN/ABTGB2Gold0.042.271.16PLIProMetic Life Sciences37.474.063.66OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABCABcann GlobalN/ABTGB2Gold61.40%PLIProMetic Life SciencesN/AInsider OwnershipCompanyInsider OwnershipABCABcann GlobalN/ABTGB2Gold1.18%PLIProMetic Life SciencesN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableABCABcann GlobalN/AN/AN/ANot OptionableBTGB2Gold6,1501.30 billion1.29 billionNot OptionablePLIProMetic Life Sciences48723.31 millionN/ANot OptionableABC, BTG, CUV, and PLI HeadlinesSourceHeadlinePanetta Institute for Public Policyscu.edu - March 31 at 4:05 PM2024 Breakthrough Prizes in Life Sciencesthe-scientist.com - October 11 at 4:23 AMTMC Life Sciences Bhd (TMCN)investing.com - July 24 at 12:48 PMLife Sciences Learning Communityslu.edu - June 13 at 7:57 PMChicago Life Sciences Summitbisnow.com - April 21 at 4:16 PMCollege of Liberal Arts & Sciencesalfred.edu - April 10 at 2:50 PMLabviva nets $20M Series A to ease life science procurement processendpts.com - March 27 at 9:38 AMTrends that will shape the life sciences industry in 2023 and beyondhindustantimes.com - February 24 at 6:14 PMPharma sector gets first tranche of payment under under PLI schememoneycontrol.com - February 24 at 6:14 PMArithmos appoints Maurizio Giraudo as Managing Director of the new Life Sciences Business Consulting Unitfinance.yahoo.com - February 21 at 12:31 PMWEF, Telangana joins hands to start thematic centre on healthcare and life scienceshealth.economictimes.indiatimes.com - January 18 at 6:06 PMWorking on PLI schemes for more sectors: Piyush Goyalretail.economictimes.indiatimes.com - September 24 at 9:00 PMTSX:CVE (CENOVUS ENERGY INC.)fool.ca - July 31 at 12:45 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsABcann GlobalCVE:ABCB2GoldNYSEAMERICAN:BTGB2Gold Corp. operates as a gold producer company. It operates the Fekola Mine in Mali, the Masbate Mine in the Philippines, and the Otjikoto Mine in Namibia. The company also has an 100% interest in the Gramalote gold project in Colombia; 24% interest in the Calibre Mining Corp.; and approximately 19% interest in BeMetals Corp. In addition, it has a portfolio of other evaluation and exploration assets in Mali and Finland. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.ProMetic Life SciencesTSE:PLIPrometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
